Search
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
(Nature Communications. vol. 12, n° 1, pp. 3417, 2021-06-07)Article de revueOpen access -
Socioeconomic inequalities in dementia risk among a French population-based cohort: quantifying the role of cardiovascular health and vascular events
(European Journal of Epidemiology, 2021-07-25)Article de revueOpen access -
Sex-tailored pharmacology and COVID-19: Next steps towards appropriateness and health equity
(Pharmacological Research. vol. 173, pp. 105848, 2021-11)Article de revueOpen access -
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study
(The Lancet global health. vol. 9, n° 4, pp. e469-e478, 2021-04)Article de revueOpen access -
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program
(International Journal of Infectious Diseases. vol. 113, pp. 166-167, 2021-09-26)Article de revueOpen access -
Immune evasion means we need a new COVID-19 social contract
(The Lancet Public Health. vol. 6, n° 4, pp. e199-e200, 2021-02)Article de revueOpen access -
Clinical presentation, outcomes and factors associated with mortality: A prospective study from three COVID-19 referral care centres in West Africa
(International Journal of Infectious Diseases. vol. 108, pp. 45-52, 2021-07)Article de revueOpen access -
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
(EBioMedicine. vol. 74, 2021-11-09)Article de revueOpen access -
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data
(The Lancet Regional Health - Europe. vol. 1, pp. 100001, 2021-02)Article de revueOpen access -
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
(Antiviral Research. vol. 193, pp. 105137, 2021-07-12)Article de revueOpen access